¼¼°èÀÇ ÀǾàǰ ÷°¡Á¦ ½ÃÀå(2025-2029³â)
Global Pharmaceutical Excipients Market 2025-2029
»óǰÄÚµå : 1714115
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 246 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,482,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,571,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀº 2024-2029³â¿¡ 52¾ï 890¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø±â°£ Áß CAGRÀº 7.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ±â´É¼º ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¦¾à »ê¾÷ÀÇ ¼ºÀå, ºÎÇüÁ¦ Á¦Á¶ ±â¼úÀÇ ¹ßÀü¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ¿¬µµ 2025³â
Á¾·á¿¬µµ 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 2025³â 6.6%
CAGR 7.7%
Áõ°¡¾× 52¾ï 890¸¸ ´Þ·¯

º» Á¶»ç´Â ¾÷°èÀÇ ÁÖ¿ä Âü°¡ÀڷκÎÅÍÀÇ ÀÎDzÀ» Æ÷ÇÔÇÑ 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸ÀÇ °´°üÀûÀÎ Á¶ÇÕÀ» »ç¿ëÇÏ¿© ½ÃÇàÇß½À´Ï´Ù. ¸®Æ÷Æ®¿¡´Â ÁÖ¿ä ±â¾÷ÀÇ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀû ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ ÀÇÇÑ ºÎ¹®, º¥´õ ±¸µµ°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¸®Æ÷Æ®¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÇâÈÄ ¼ö³â°£ ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ¼ÒºñÇϱ⠽¬¿î ÀǾàǰÀ» °³¹ßÇϱâ À§ÇÑ »õ·Î¿î ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ²Å°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³ëÈ­ °ü·Ã Áúº´ ¹× ±âŸ Áúº´ÀÇ ¹ß»ý·ü Áõ°¡, 1Àδç ÁöÃâ Áõ°¡µµ ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç°º°

Á¦10Àå ½ÃÀå ¼¼ºÐÈ­ : Åõ¿© °æ·Îº°

Á¦11Àå ½ÃÀå ¼¼ºÐÈ­ : ÆûÆÑÅͺ°

Á¦12Àå °í°´ »óȲ

Á¦13Àå Áö¿ªº° »óȲ

Á¦14Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå °æÀï ºÐ¼®

Á¦17Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The pharmaceutical excipients market is forecasted to grow by USD 5208.9 mn during 2024-2029, accelerating at a CAGR of 7.7% during the forecast period. The report on the pharmaceutical excipients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for functional excipients, growth in pharmaceutical industry, and evolution in techniques used to produce excipients.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.6%
CAGR7.7%
Incremental Value$5208.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's pharmaceutical excipients market is segmented as below:

By Type

By Product

By Route Of Administration

By Form Factor

By Geographical Landscape

This study identifies the demand for new excipients to develop easily consumable drugs as one of the prime reasons driving the pharmaceutical excipients market growth during the next few years. Also, increasing incidence of age-related and other ailments and increasing per capita expenditure will lead to sizable demand in the market.

The report on the pharmaceutical excipients market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical excipients market vendors that include Actylis, Air Liquide SA, Archer Daniels Midland Co., Ashland Inc., Associated British Foods Plc, Avantor Inc., BASF SE, Colorcon Inc., Croda International Plc, DFE Pharma GmbH and Co. KG, Evonik Industries AG, Innophos Holdings Inc., J M Huber Corp., JRS PHARMA GmbH and Co. KG, Kerry Group Plc, Merck and Co. Inc., Roquette Freres SA, The Dow Chemical Co., The Lubrizol Corp., and Wacker Chemie AG. Also, the pharmaceutical excipients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Type

9 Market Segmentation by Product

10 Market Segmentation by Route of Administration

11 Market Segmentation by Form Factor

12 Customer Landscape

13 Geographic Landscape

14 Drivers, Challenges, and Opportunity/Restraints

15 Competitive Landscape

16 Competitive Analysis

17 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â